Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Sep;89(5):366-371.
doi: 10.1111/ahg.70008. Epub 2025 Jul 5.

The Promise and Challenges of Genomics for Patients and Families Affected by Rare Conditions

Affiliations
Review

The Promise and Challenges of Genomics for Patients and Families Affected by Rare Conditions

Claire A Andersen et al. Ann Hum Genet. 2025 Sep.

Abstract

Availability and implementation of genetic testing on a national and global level have advanced exponentially over the last few decades. While having a diagnosis of a rare genetic condition can have a plethora of effects on those concerned, the delivery of a diagnosis can often be accompanied by little information and no obvious care path for the future. Continued advancements in genomics have curtailed often lengthy diagnostic odysseys but also highlighted inequities and the need for extended support and provision of related information. Unique, a UK-based charity serving the global community of people and families affected by rare chromosome and gene disorders associated with developmental delay and/or intellectual disability, aims to bridge the knowledge and care gap between diagnosis and follow-up care. Bringing together patients, families, research scientists, clinical geneticists and other professionals involved in the care of individuals with a rare genetic condition can have a powerful impact on the progress of targeted support. With a community of over 30,000 member families, sharing knowledge and experience of rare genetic disorders, and also experiences of diagnosis delivery and follow-up care, this community provides an important source of insights and actionable concerns of those experiencing a rare disease journey, from diagnosis and throughout life.

Keywords: neurodevelopmental disorders; patient support; rare chromosome disorder; rare gene disorder.

PubMed Disclaimer

References

    1. Blöß, S., C. Klemann, A. K. Rother, et al. 2017. “Diagnostic Needs for Rare Diseases and Shared Prediagnostic Phenomena: Results of a German‐Wide Expert Delphi Survey.” PLoS ONE 12, no. 12: e0172532.
    1. Chen, Y., R. Dawes, H. C. Kim, et al. 2024. “De Novo Variants in the RNU4‐2 snRNA Cause a Frequent Neurodevelopmental Syndrome.” Nature 632, no. 8026: 8832–8840.
    1. Copeland, H., K. J. Low, S. L. Wynn, et al. 2024. “Large‐scale Evaluation of Outcomes After a Genetic Diagnosis in Children With Severe Developmental Disorders.” Genetics in Medicine Open 2: 101864.
    1. Deciphering Developmental Disorders Study. 2017. “Prevalence and Architecture of De Novo Mutations in Developmental Disorders.” Nature 542, no. 7642: 433–438. https://doi.org/10.1038/nature21062.
    1. DHSC. 2019. Government response to the House of Commons Science and Technology Committee's Third Report of Session 2017–19, ‘Genomics and Genome Editing in the NHS’.

LinkOut - more resources